Cargando…

Clinical Outcomes of Chemotherapeutic Molecules as Single and Multiple Agents in Advanced Non-Small-Cell Lung Carcinoma (NSCLC) Patients

Background and Objectives: Lung cancer is the second most common cancer in the world. Non-small-cell lung carcinoma (NSCLC) makes up 85% of all lung cancer cases and the majority of patients are diagnosed when the cancer is advanced. Over the years, many anticancer drugs have been designed and intro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kwan, Ting Yoon, Chowdhury, Ezharul Hoque
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618045/ https://www.ncbi.nlm.nih.gov/pubmed/34833470 http://dx.doi.org/10.3390/medicina57111252

Ejemplares similares

Nanoparticles Targeting Receptors on Breast Cancer for Efficient Delivery of Chemotherapeutics
por: Jahan, Sulltana, et al.
Publicado: (2021)

PH-responsive strontium nanoparticles for targeted gene therapy against mammary carcinoma cells
por: Bakhtiar, Athirah, et al.
Publicado: (2021)

Hydrophilic Small Molecules That Harness Transthyretin To Enhance the Safety and Efficacy of Targeted Chemotherapeutic Agents
por: Pal, Arindom, et al.
Publicado: (2019)

Accidental Overdose of Multiple Chemotherapeutic Agents
por: Kim, In Soon, et al.
Publicado: (1989)

Cytotoxicity Enhancement in Breast Cancer Cells with Carbonate Apatite-Facilitated Intracellular Delivery of Anti-Cancer Drugs
por: Fatemian, Tahereh, et al.
Publicado: (2018)

Retarding breast tumor growth with nanoparticle-facilitated intravenous delivery of BRCA1 and BRCA2 tumor suppressor genes
por: Ibnat, Nabilah, et al.
Publicado: (2023)

Citrate- and Succinate-Modified Carbonate Apatite Nanoparticles with Loaded Doxorubicin Exhibit Potent Anticancer Activity against Breast Cancer Cells
por: Mehbuba Hossain, Sultana, et al.
Publicado: (2018)

Surface-Modification of Carbonate Apatite Nanoparticles Enhances Delivery and Cytotoxicity of Gemcitabine and Anastrozole in Breast Cancer Cells
por: Mozar, Fitya Syarifa, et al.
Publicado: (2017)

PEGylated Strontium Sulfite Nanoparticles with Spontaneously Formed Surface-Embedded Protein Corona Restrict Off-Target Distribution and Accelerate Breast Tumour-Selective Delivery of siRNA
por: Karim, Md. Emranul, et al.
Publicado: (2022)

Evaluation of Chemotherapeutic Agents
por: Engstrom, W. W.
Publicado: (1949)

Intracellular Delivery of siRNAs Targeting AKT and ERBB2 Genes Enhances Chemosensitization of Breast Cancer Cells in a Culture and Animal Model
por: Fatemian, Tahereh, et al.
Publicado: (2019)

Targeting Cell Adhesion Molecules via Carbonate Apatite-Mediated Delivery of Specific siRNAs to Breast Cancer Cells In Vitro and In Vivo
por: Ashaie, Maeirah Afzal, et al.
Publicado: (2019)

Carbonate apatite nanoparticles carry siRNA(s) targeting growth factor receptor genes egfr1 and erbb2 to regress mouse breast tumor
por: Tiash, Snigdha, et al.
Publicado: (2017)

Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cells
por: Sei, Shizuko, et al.
Publicado: (2009)

Advances in radiological staging of non-small cell lung cancer (NSCLC)
por: Rankin, S C
Publicado: (2004)

Discovery of Small Molecule COX-1 and Akt Inhibitors as Anti-NSCLC Agents Endowed with Anti-Inflammatory Action
por: Altıntop, Mehlika Dilek, et al.
Publicado: (2023)

siRNAs Targeting Growth Factor Receptor and Anti-Apoptotic Genes Synergistically Kill Breast Cancer Cells through Inhibition of MAPK and PI-3 Kinase Pathways
por: Kamaruzman, Nur Izyani, et al.
Publicado: (2018)

Krebs Cycle Intermediate-Modified Carbonate Apatite Nanoparticles Drastically Reduce Mouse Tumor Burden and Toxicity by Restricting Broad Tissue Distribution of Anticancer Drugs
por: Hossain, Sultana Mehbuba, et al.
Publicado: (2020)

Editorial: Non-coding RNAs in diseases of the nervous system
por: Reschke, Cristina R., et al.
Publicado: (2023)

Small-Molecule Procaspase-3 Activation Sensitizes Cancer to Treatment with Diverse Chemotherapeutics
por: Botham, Rachel C., et al.
Publicado: (2016)

Dichloroacetate enhances the antitumor efficacy of chemotherapeutic agents via inhibiting autophagy in non-small-cell lung cancer
por: Lu, Xiao, et al.
Publicado: (2018)

A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment
por: Wang, Da, et al.
Publicado: (2019)

α-Ketoglutaric Acid-Modified Carbonate Apatite Enhances Cellular Uptake and Cytotoxicity of a Raf-Kinase Inhibitor in Breast Cancer Cells through Inhibition of MAPK and PI-3 Kinase Pathways
por: Hossain, Sultana Mehbuba, et al.
Publicado: (2019)

Effect of Various Chemotherapeutic Agents on Metastasis
por: Lapis, K., et al.
Publicado: (1956)

Nail Changes Induced by Chemotherapeutic Agents
por: Saraswat, Neerja, et al.
Publicado: (2020)

Anesthesia Medications and Interaction with Chemotherapeutic Agents
por: Watson, Jeremy, et al.
Publicado: (2021)

Non-small cell lung carcinoma (NSCLC): Implications on molecular pathology and advances in early diagnostics and therapeutics
por: Padinharayil, Hafiza, et al.
Publicado: (2022)

Single-agent maintenance therapy for advanced non-small cell lung cancer (NSCLC): a systematic review and Bayesian network meta-analysis of 26 randomized controlled trials
por: Wang, Qinxue, et al.
Publicado: (2016)

Targeting potential receptor molecules in non-small cell lung cancer (NSCLC) using in silico approaches
por: Kirubhanand, C., et al.
Publicado: (2023)

Effect of Chemotherapeutics on In Vitro Immune Checkpoint Expression in Non-Small Cell Lung Cancer
por: Zhao, Yu, et al.
Publicado: (2023)

Chemotherapeutic Agents for the Treatment of Hepatocellular Carcinoma: Efficacy and Mode of Action
por: Shaaban, Saad, et al.
Publicado: (2014)

Reversing multidrug resistance in breast cancer cells by silencing ABC transporter genes with nanoparticle-facilitated delivery of target siRNAs
por: Li, Yong Tsuey, et al.
Publicado: (2012)

Oncogenic Signaling in Tumorigenesis and Applications of siRNA Nanotherapeutics in Breast Cancer
por: Kamaruzman, Nur Izyani, et al.
Publicado: (2019)

Characterization and Evaluation of Bone-Derived Nanoparticles as a Novel pH-Responsive Carrier for Delivery of Doxorubicin into Breast Cancer Cells
por: Haque, Sheikh Tanzina, et al.
Publicado: (2020)

Insulin-Loaded Barium Salt Particles Facilitate Oral Delivery of Insulin in Diabetic Rats
por: Zaman, Rahela, et al.
Publicado: (2020)

Pemetrexed as second-line therapy for advanced non-small-cell lung cancer (NSCLC)
por: Felip, Enriqueta, et al.
Publicado: (2008)

Combination of immunotherapy with targeted therapies in advanced non-small cell lung cancer (NSCLC)
por: Moya-Horno, Irene, et al.
Publicado: (2018)

First-line single agent treatment with gefitinib in patients with advanced non-small-cell lung cancer
por: Yin, Yong-Mei, et al.
Publicado: (2010)

The role of expression and polymorphism of the BAG-1 gene in response to platinum-based chemotherapeutics in NSCLC
por: WANG, YA-DI, et al.
Publicado: (2011)

Small molecules inhibiting the nuclear localization of YAP/TAZ for chemotherapeutics and chemosensitizers against breast cancers
por: Oku, Yusuke, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9ri2actcq38jjomcibqjtfpbku